Targeting p53-MDM2 interactions to identify small molecule inhibitors for cancer therapy: beyond “Failure to rescue”-Reference-Cited by-同舟云学术

Targeting p53-MDM2 interactions to identify small molecule inhibitors for cancer therapy: beyond “Failure to rescue”

Published:2021-05-14 Issue: Volume: Page:1-19
ISSN:0739-1102
Container-title:Journal of Biomolecular Structure and Dynamics
language:en
Short-container-title:Journal of Biomolecular Structure and Dynamics

Author:

Chukwuemeka Prosper Obed¹^ORCID,Umar Haruna Isiyaku²^ORCID,Iwaloye Opeyemi³^ORCID,Oretade Oluwaseyi Matthew¹^ORCID,Olowosoke Christopher Busayo¹^ORCID,Elabiyi Michael Omoniyi⁴,Igbe Festus Omotere²,Oretade Oyeyemi Janet⁵,Eigbe Joy Oseme⁶,Adeojo Funmilayo Janet¹^ORCID

Affiliation:

1. Department of Biotechnology, School of Sciences (SOS), Federal University of Technology Akure, Akure, Nigeria

2. Department of Biochemistry, School of Sciences (SOS), Federal University of Technology Akure, Akure, Nigeria

3. Bioinformatics and Molecular biology unit, Department of Biochemistry, School of Sciences (SOS), Federal University of Technology Akure, Akure, Nigeria

4. Department of Microbiology, School of Sciences (SOS), Federal University of Technology Akure, Akure, Nigeria

5. Department of Physiology, College of Health Science (CHS), Osun State University, Osogbo, Nigeria

6. Department of Biomedical Technology, School of Health and Health Technology (SHHT), Federal University of Technology Akure, Akure, Nigeria

Publisher

Informa UK Limited

Subject

Molecular Biology,General Medicine,Structural Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/07391102.2021.1924267

Reference69 articles.

1. Pharmacophore and docking-based sequential virtual screening for the identification of novel Sigma 1 receptor ligands

2. Discovery and Optimization of Chromenotriazolopyrimidines as Potent Inhibitors of the Mouse Double Minute 2−Tumor Protein 53 Protein−Protein Interaction